Daniel Brown

Dan Browne

CEO & President

Revance Therapeutics

Biography

Dan Browne is a co-founder of the company and has served as our President, Chief Executive Officer and a member of the board of directors since operations commenced in 2002. Prior to starting Revance, Mr. Browne served as President and Chief Executive Officer of Neomend, Inc., a biologics and biomaterials company; he served as President of Prograft Medical Inc., a developer of peripheral vascular stents and stent-grafts. Previously, Mr. Browne spent more than 16 years in various leadership positions in product development, sales and marketing and business development in the GORE-TEX Medical Products Division of W.L. Gore & Associates, Inc., a global technology company, serving as Business Leader in the Medical Products Division as his final role at the company.

Join Us on April 25, 2018 at The New York Marriott Marquis